When reporting studies on human subjects, all authors are required to follow the ICMJE requirements on privacy and informed consent. Information that could be used to identify patients, including written descriptions, photographs, and pedigrees, should not be published unless it is essential for scientific purposes and the patient (or parent or guardian) provides written informed consent for publication. Informed consent for this purpose requires that the patient be shown the manuscript to be published. Where a participant is deceased, written consent must be obtained from the family or estate.

Clinical trials and studies involving animal experiments must be approved by a local ethics committee. Researchers are strongly encouraged to register clinical trials in public trial registries, such as https://www.clinicaltrials.gov/. Trial registration numbers should be included, with full details provided in the Methods section.

Publication Ethics and Malpractice Statement

Editorial Responsibilities

• The Editorial Board ensures that all submissions are evaluated impartially based on scholarly merit, originality, and relevance, without discrimination based on race, gender, nationality, or political beliefs.
• Editors and editorial staff maintain strict confidentiality regarding submitted manuscripts and do not disclose information to unauthorized individuals.
• Any plagiarism, data falsification, or research misconduct identified will result in immediate rejection or withdrawal of the manuscript.
• The editorial team follows COPE (Committee on Publication Ethics) guidelines for handling complaints, disputes, and ethical concerns.

Author Responsibilities

• Authors must submit original, unpublished work and properly cite all sources to prevent plagiarism and self-plagiarism.
• Fabrication, falsification, and any other unethical research practices are strictly prohibited.
• All listed authors must have made significant contributions to the research and approved the final manuscript.
• Authors must disclose any financial or personal conflicts of interest and acknowledge all funding sources.
• If errors are discovered after publication, authors must promptly notify the journal so that corrections or retractions can be issued.

Peer Review Process

• AMMS follows a single-blind peer review process in which reviewers remain anonymous while authors’ identities are disclosed.
• Reviewers are expected to provide constructive and unbiased feedback and disclose any potential conflicts of interest.
• Manuscripts containing plagiarism, fraudulent data, or ethical violations will be rejected or retracted.

Publisher Responsibilities

• The publisher ensures that all ethical policies are implemented and maintains the integrity, transparency, and academic quality of the journal.
• Any reported ethical misconduct will be thoroughly investigated, and appropriate corrections or retractions will be published when necessary.
• The journal complies with internationally accepted standards for ethical publishing.

Plagiarism and Ethical Misconduct

• The journal uses plagiarism detection software such as Turnitin and iThenticate to verify originality.
• Detected plagiarism, duplicate submission, or data fabrication will result in immediate rejection or retraction.
• Authors found responsible for serious ethical misconduct may be prohibited from making future submissions.

Conflicts of Interest

• Authors, reviewers, and editors must disclose any financial or personal conflicts of interest that could influence the research, review, or publication process.